This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients' gender. The results suggest the opportunity of an early isotretinoin systemic treatment in patients affected by moderate acne and emphasize the importance of an appropriate dose adjustment in order to minimize adverse events.
Advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data / Skroza, N; Tolino, E; Balduzzi, V; Bernardini, N; Mambrin, A; Marchesiello, A; Marraffa, F; Rossi, G; Volpe, S; Proietti, I; Potenza, C.. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 12:(2021). [10.3389/fphar.2021.733526]
Advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data
Skroza N;Tolino E
;Balduzzi V;Bernardini N;Mambrin A;Marchesiello A;Marraffa F;Rossi G;Volpe S;Proietti I;Potenza C.
2021
Abstract
This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients' gender. The results suggest the opportunity of an early isotretinoin systemic treatment in patients affected by moderate acne and emphasize the importance of an appropriate dose adjustment in order to minimize adverse events.| File | Dimensione | Formato | |
|---|---|---|---|
|
Skroza_Advantages_2021.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
541.62 kB
Formato
Adobe PDF
|
541.62 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
